The logical dose

Novartis vS. Indian patent act, it is a  landmark decision  by a two-judge bench of the  Indian Supreme Court  on the issue of whether  Novartis  could patent  Gleevec . (Which is  Imatinib, sold under the brand names Gleevec , is a chemotherapy medication used to treat cancer.)  The Supreme Court upheld the Indian patent office's rejection of the patent application. summary of case: The total duration of this case was 16 years if we consider from 1997 when Novartis filed patent application for glavac .  In 2005 india had a new patent law and  the patent controller has denied the patent to novartis in 2006 what is filed an application in Madras High Court. And in 2007 raj High Court hindi action by Novartis and in 2009 novartis send for Supreme Court and 2013 on 1 st April the supreme court rejected the plea.   History of indian patent law:  after gaining independence in 1947, there was a growing consensus that to boost manufacturing restrictive product patents mu